Ad is loading...
MENU

ONCY Oncolytics Biotech Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products for the treatment of cancers

Industry Biotechnology
ONCY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ONCY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ONCY is expected to report earnings to fall 28.33% to -8 cents per share on March 06

Oncolytics Biotech ONCY Stock Earnings Reports
Q4'24
Est.
$-0.09
Q3'24
Missed
by $0.02
Q2'24
Est.
$-0.10
Q1'24
Beat
by $0.02
Q4'23
Beat
by $0.10
The last earnings report on November 12 showed earnings per share of -11 cents, missing the estimate of -10 cents. With 346.04K shares outstanding, the current market capitalization sits at 73.32M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products for the treatment of cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
322 11th Avenue S.W
Phone
+1 403 670-7377
Employees
26
Web
https://www.oncolyticsbiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORGN1.190.16
+15.53%
Origin Materials
AZN64.261.06
+1.68%
AstraZeneca PLC
KAR19.840.18
+0.92%
OPENLANE
FCN198.18-0.80
-0.40%
FTI Consulting
OLMA7.87-0.41
-4.95%
Olema Pharmaceuticals

ONCY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ONCY has been loosely correlated with SRRK. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCY jumps, then SRRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCY
1D Price
Change %
ONCY100%
-1.85%
SRRK - ONCY
38%
Loosely correlated
-4.27%
ABCL - ONCY
34%
Loosely correlated
+1.87%
RCUS - ONCY
27%
Poorly correlated
-2.33%
UBX - ONCY
27%
Poorly correlated
-0.85%
VCYT - ONCY
27%
Poorly correlated
-0.66%
More